Author

L Ambrozi

Observed names: L AMBROZI, L. Ambrozi

Observed institutions: Ludwig Boltzmann für Klinische Neurobiologie, Wiener Krankenanstaltenverbund

OpenAlex ID: A5022431832

Implications of Combined Treatment With 'madopar' and L-deprenil in Parkinson's Disease

1977 · W Birkmayer, P Riederer, et al. · The Lancet · 297

Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study

1988 · L. Ambrozi, W. Danielczyk · Pharmacopsychiatry · 48

The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depressionsyndrom

1974 · P. Riederer, W. Birkmayer, et al. · Journal of Neural Transmission · 32

Levodopa in the treatment of (PRE) senile dementia

1980 · K. Jellinger, H. Flament, et al. · Mechanisms of Ageing and Development · 18

Quantitative Dissection of Human Brain Areas: Relevance to Transmitter Analyses

1980 · St. Wuketich, P. Riederer, et al. · Springer eBooks · 13

Longevity in Parkinson's disease treated with L-DOPA

1974 · W. Birkmayer, L. Ambrozi, et al. · Clinical Neurology and Neurosurgery · 9

Die Objektivierbarkeit psychopharmakologischer Drogen am Beispiel von Metylperon

2017 · L. Ambrozi, W. Birkmayer, et al. · International Pharmacopsychiatry · 6

[Cerebrovascular insufficiency and cerebral function].

1971 · L Ambrozi, E Mneumayer · PubMed · 3

Objectivation of latent psychoses

1977 · L. Ambrozi, E. Langner · Journal of Neural Transmission · 2

[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)].

1974 · L Ambrozi, P Riederer, et al. · PubMed · 2

[Use of psychological testing technics in sequellae of brain injuries].

1969 · L Ambrozi, R Quatember · PubMed · 2

L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings].

1976 · L Ambrozi, W Birkmayer, et al. · PubMed Central · 1

[Possibility for assay of psychopharmacological drugs in the example of caffeine and caffeine-free coffee].

1970 · L Ambrozi, W Birkmayer · PubMed · 1

[improvement of Cerebral Function by Pyrithioxine].

1964 · L AMBROZI, I PRAMER · PubMed · 1

[The pharmaco-dynamic alteration of the thalamo-reticular system as a therapeutic principle in psychiatry].

1960 · L AMBROZI, W BIRKMAYER, et al. · PubMed · 1

[Differentiation between postencephalitic parkinsonism and Parkinson's disease by the Rorschach test].

1958 · L AMBROZI, W BIRKMAYER · PubMed · 1

[Attitudes toward abnormal reactions and attitudes].

1955 · L AMBROZI · PubMed · 1

[Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].

1982 · L Ambrozi, J Bruck, et al. · PubMed

[Biochemical aspects of human behaviour (author's transl)].

1973 · L Ambrozi, W Birkmayer, et al. · PubMed

[The function of the psychologist in a neurological department].

1973 · L Ambrozi · PubMed

[Biochemical aspects of human behavior].

1973 · L Ambrozi, W Birkmayer, et al. · PubMed

[Objectivity in psychopharmacology].

1973 · L Ambrozi · PubMed

[Affective vegetative excitation patterns and their polygraphic registration].

1969 · L Ambrozi · PubMed

[Melitracene as an antidepressive agent].

1967 · L Ambrozi, W Birkmayer · PubMed

[On the terapy of senile depression with protriptyline].

1967 · L Ambrozi, W Birkmayer · PubMed

Works count: 31

Citation count: 438

H-index: 6

I10-index: 5